Hyder, Z.; Harkness, E.F.; Woodward, E.R.; Bowers, N.L.; Pereira, M.; Wallace, A.J.; Howell, S.J.; Howell, A.; Lalloo, F.; Newman, W.G.;
et al. Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer. Cancers 2020, 12, 378.
https://doi.org/10.3390/cancers12020378
AMA Style
Hyder Z, Harkness EF, Woodward ER, Bowers NL, Pereira M, Wallace AJ, Howell SJ, Howell A, Lalloo F, Newman WG,
et al. Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer. Cancers. 2020; 12(2):378.
https://doi.org/10.3390/cancers12020378
Chicago/Turabian Style
Hyder, Zerin, Elaine F. Harkness, Emma R. Woodward, Naomi L. Bowers, Marta Pereira, Andrew J. Wallace, Sacha J. Howell, Anthony Howell, Fiona Lalloo, William G. Newman,
and et al. 2020. "Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer" Cancers 12, no. 2: 378.
https://doi.org/10.3390/cancers12020378
APA Style
Hyder, Z., Harkness, E. F., Woodward, E. R., Bowers, N. L., Pereira, M., Wallace, A. J., Howell, S. J., Howell, A., Lalloo, F., Newman, W. G., Smith, M. J., & Evans, D. G.
(2020). Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer. Cancers, 12(2), 378.
https://doi.org/10.3390/cancers12020378
